Clinical Trials Logo

Clinical Trial Summary

Irritable Bowel syndrome (IBS) is a very frequent condition in children. Its management is difficult, often resulting in a persistence of chronical abdominal pain.

In adults, many patients affected by IBS improve under a gluten-free diet, even in the absence of Celiac Disease (CD) or wheat allergy. This condition is called Non Coeliac Gluten Sensitivity (NCGS). However, it is still not clear how to diagnose and manage NCGS, and the pathophysiological mechanisms also remain elusive.

The aim of this study is to determine if NCGS exists in children with IBS and to identify the clinical, serological, and histological characteristics, which could distinguish patients with NCGS from conventional IBS and CD patients.

This is a prospective cohort study in a population of children affected by a moderate to severe IBS for more than 6 months. All children had a Gluten Free Diet (GFD) for 6 weeks. Then, children who improved under GFD were randomized in two groups for a double-blind placebo-controled trial. One group had a reintroduction of gluten followed by a wash-out period, then a placebo reintroduction, whereas the other group had the placebo first, then the wash-out and the gluten reintroduction.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02895438
Study type Interventional
Source Centre Hospitalier Universitaire de Saint Etienne
Contact Sylvie DESTOMBE, MD
Phone (0)4 77 82 81 34
Email sylvie.destombe@chu-st-etienne.fr
Status Recruiting
Phase N/A
Start date April 2014
Completion date February 2018

See also
  Status Clinical Trial Phase
Recruiting NCT01893775 - Antibody Treatment for Advanced Celiac Disease Phase 1